PCN294 DERIVATION OF UTILITY VALUES FOR PATIENTS WITH ADVANCED HEPATOCELULAR CARCINOMA BASED ON HRQOL DATA FROM THE PHASE 3 CELESTIAL TRIAL
Abstract
Authors
P. Mollon N. Freemantle F. Benzaghou V. Valcheva I. Guerra S. McKaig M. Roset E. Sanchez